March 24, 2011
As our economy begins to improve, job creation remains a critical priority toward ensuring a broad, deep and sustained recovery. To that end, legislation to strengthen our patent system will drive job growth by encouraging additional investments in R&D, as well as creating a vibrant environment conducive to greater innovation – all without adding to the deficit.
The Senate’s overwhelmingly bipartisan vote on patent reform represents a rare opportunity to make progress in this critical area. Similarly, the House Judiciary Committee’s recent hearings have helped build the basis upon which patent reform legislation could move quickly in the House of Representatives as well.
As highlighted recently by Director David Kappos in his testimony before the House Judiciary Committee, our patent system is in dire need of the appropriate tools for modernization and adequate funding for the United States Patent and Trademark Office (USPTO). Comprehensive patent reform will ensure that the examination and approval processes work efficiently and provide certainty so that businesses, small and large, can place new and innovative products in the market. And, a predictable and dedicated revenue stream for the PTO, with full access to all the fees it collects, will help get breakthrough products to market faster, maximizing our opportunities for job growth.
As leading manufacturers, scientists, researchers, academic institutions, and businesses, small and large, we stand ready to assist you in your efforts to improve the patent system and unleash the creative and technical talents of American innovation. We cannot afford to wait. It is our hope that patent reform legislation can be enacted into law this year and we look forward to working with you to achieve this goal.
Air Products and Chemicals, Inc.
American Council on Education
American Institute of Certified Public
American Intellectual Property Law
Arizona State University
Association of American Medical Colleges
Association of American Universities
Association of Public and Land-grant
Association of University Technology
Beckman Coulter Inc.
Bio Nebraska Life Sciences Association
Biotechnology Industry Organization
Bridgestone Americas, Inc.
California Healthcare Institute, Inc.
Colorado Bioscience Association
Connecticut United for Research Excellence,
Danisco US Inc. – Genencor
The Dow Chemical Company
Duke University School of Medicine
Eastman Chemical Company
Eli Lilly & Company
Exxon Mobil Corporation
HealthCare Institute of New Jersey
Illinois Biotechnology Industry
Illinois Tool Works
Indiana Health Industry Forum
Intellectual Property Owners Association
International Game Technology
Iowa Biotech Association
Iowa State University
Isis Pharmaceuticals, Inc.
Johnson & Johnson
LifeScience Alley and the BioBusiness
Alliance of Minnesota
Massachusetts Biotechnology Council
Merck & Co., Inc.
Milliken & Company
Missouri Biotechnology Association
North Carolina Biosciences Organization
North Carolina State University
Novozymes North America Inc.
Pharmaceutical Research and Manufacturers
Procter & Gamble
Southern California Biomedical Council
Stony Brook University, State University of
Texas Healthcare and Bioscience Institute
The Ohio State University
University of Illinois
University of Michigan
University of North Carolina at Chapel Hill
University of Pittsburgh
University of Utah Health Sciences
University of Wisconsin-Madison
Vertex Pharmaceuticals, Inc.
Virginia Biotechnology Association
Washington Biotechnology & Biomedical
Washington University in St. Louis